Literature DB >> 8573095

Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs.

T Wisniewski1, M Lalowski, M Bobik, M Russell, J Strosznajder, B Frangione.   

Abstract

In alzheimer's disease, amyloid beta (A beta) is deposited in senile plaques and amyloid angiopathy. Longer A beta peptides, which extend to residue 42 (A beta 42), have been suggested to be critical for the seeding of amyloid. Aged dogs develop cerebral vessel amyloid and parenchymal preamyloid lesions. Preamyloid in humans is related to senile plaques, whereas in dogs such progression is rare. We evaluated the composition of aged canine vessel amyloid and preamyloid both biochemically and immunohistochemically. The vessel amyloid extended mainly to residue 40 (A beta 40), while preamyloid contained a mixture of A beta 17-42 and A beta 42, with minimal A beta 40. Our results suggest other factors besides A beta 42 are important for neuritic plaque formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8573095      PMCID: PMC1216946          DOI: 10.1042/bj3130575

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain.

Authors:  J Motte; R S Williams
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Senile plaque-like structures: observation of a probably unknown type of senile plaque by periodic-acid methenamine silver (PAM) electron microscopy.

Authors:  K Ikeda; C Haga; K Kosaka; S Oyanagi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

Authors:  L Davies; B Wolska; C Hilbich; G Multhaup; R Martins; G Simms; K Beyreuther; C L Masters
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

4.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.

Authors:  D M Mann
Journal:  Neurobiol Aging       Date:  1989 Sep-Oct       Impact factor: 4.673

6.  Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

Authors:  F Tagliavini; G Giaccone; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

7.  Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders.

Authors:  G M Murphy; L S Forno; L Higgins; J M Scardina; L F Eng; B Cordell
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

8.  Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

Authors:  C L Joachim; L K Duffy; J H Morris; D J Selkoe
Journal:  Brain Res       Date:  1988-11-22       Impact factor: 3.252

9.  Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein.

Authors:  K Ueda; Y Fukui; H Kageyama
Journal:  Brain Res       Date:  1994-03-14       Impact factor: 3.252

10.  Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

Authors:  G Giaccone; F Tagliavini; G Linoli; C Bouras; L Frigerio; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1989-02-13       Impact factor: 3.046

View more
  9 in total

1.  β-Barrel topology of Alzheimer's β-amyloid ion channels.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Ricardo Capone; Ratnesh Lal; Ruth Nussinov
Journal:  J Mol Biol       Date:  2010-10-21       Impact factor: 5.469

2.  Presenilin-1 is associated with Alzheimer's disease amyloid.

Authors:  T Wisniewski; W K Dowjat; B Permanne; J Palha; A Kumar; G Gallo; B Frangione
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Neurobiology of the aging dog.

Authors:  Elizabeth Head
Journal:  Age (Dordr)       Date:  2010-09-16

4.  Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Ricardo Capone; Rushana Azimova; Bruce L Kagan; Ruth Nussinov; Ratnesh Lal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

5.  Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines.

Authors:  Elizabeth Head; Viorela Pop; Floyd Sarsoza; Rakez Kayed; Tina L Beckett; Christa M Studzinski; Jennifer L Tomic; Charles G Glabe; M Paul Murphy
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Neuropathology of Aging in Cats and its Similarities to Human Alzheimer's Disease.

Authors:  Lorena Sordo; Alessandra C Martini; E Fiona Houston; Elizabeth Head; Danièlle Gunn-Moore
Journal:  Front Aging       Date:  2021-06-07

7.  Differences in doublecortin immunoreactivity and protein levels in the hippocampal dentate gyrus between adult and aged dogs.

Authors:  In Koo Hwang; Ki-Yeon Yoo; Hua Li; Jung Hoon Choi; Young-Guen Kwon; Youngkeun Ahn; In Se Lee; Moo Ho Won
Journal:  Neurochem Res       Date:  2007-05-19       Impact factor: 3.996

Review 8.  Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.

Authors:  Paulina R Davis; Elizabeth Head
Journal:  Front Pharmacol       Date:  2014-03-21       Impact factor: 5.810

9.  Natural non-trasgenic animal models for research in Alzheimer's disease.

Authors:  Manuel Sarasa; Pedro Pesini
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.